On Friday, a long winning streak for Monsanto concerning trials regarding their herbicide product, Roundup, was brought to an end in St. Louis. A jury awarded the plaintiff, John Durnell, $1.25 million, marking the first jury award for a Roundup plaintiff since before the COVID-19 pandemic and waylaying Monsanto’s nine-trial winning streak.
The focus of these trials has been the potential risks of Roundup’s active ingredient, glyphosate, which Durnell alleges caused his non-Hodgkin lymphoma diagnosed at age 67. The jury in this case sided with Durnell’s assertion that Monsanto had failed to adequately warn about these possible health hazards.
However, it is important to note that while the jury concluded that Monsanto failed in their duty to warn, they rejected claims that the company had been negligent in designing a defective product. Additionally, they did not award any punitive damages to Durnell. The details of this case can give legal professionals valuable insights into the legal landscape around manufacturer responsibility and product liability.
As the first significant loss for Monsanto in these Roundup related trials, legal professionals and corporate entities alike will be keeping a close eye on how the company responds and whether this case will set a trend for future lawsuits. More information about this case can be found in the original Law.com article.